# Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension

> **NCT02226094** · PHASE1,PHASE2 · TERMINATED · sponsor: **OcuTherix, Inc.** · enrollment: 35 (actual)

## Conditions studied

- Primary Open-angle Glaucoma (POAG)
- Ocular Hypertension (OHT)

## Interventions

- **DEVICE:** DWT device dose A
- **DEVICE:** Ellex Tango SLT machine
- **DEVICE:** DWT device dose B
- **DEVICE:** DWT sham

## Key facts

- **NCT ID:** NCT02226094
- **Lead sponsor:** OcuTherix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11
- **Primary completion:** 2015-06
- **Final completion:** 2015-12
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02226094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02226094, "Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02226094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*